102671-69-2

Upstream product

• 102671-70-5 (R)-5-(2-fluorophenyl)-1,3-dihydro-3-(1H-indol-3-ylmethyl)-2H-1,4-benzodiazepin-2-one 
• 1581-13-1 2-amino-2'-fluorobenzophenone 
• 103222-66-8 D-tryptophan acid chloride hydrochloride 
• 103342-80-9 2-N-(D-tryptophanyl)amino-2'-fluorobenzophenonehydrochloride 
• 19172-47-5 Lawessons reagent 

Downstream Products

• 111581-47-6 1,1-dimethylethyl <5-(2-fluorophenyl)-3-(1H-indol-3-ylmethyl)-3H-1,4-benzodiazepine-2-ylamino>acetate 
• 103195-63-7 1-Trichloromethyl-4(R)-(3'-indolyl)methyl-6-(2-fluorophenyl)-4H-S-triazolo[4,3-a]-1,4-benzodiazepine 
• 103195-60-4 (R)-6-(2-fluorophenyl)-4-(1H-indol-3-ylmethyl)-N,N-dimethyl-4H-<1,2,4>triazolo<4,3-a><1,4>benzodiazepine-1-methanamide 
• 103195-58-0 6-(2-Fluorophenyl)-4(R)-4-(3'-indolyl)methyl-1-phenyl-4H-s-triazolo[4,3-a]-1,4-benzodiazepine 
• 103195-59-1 (R)-6-(2-fluorophenyl)-4-(1H-indol-3-ylmethyl)-4H-<1,2,4>triazolo<4,3-a><1,4>benzodiazepine 
• 103195-57-9 (R)-6-(2-fluorophenyl)-4-(1H-indol-3-ylmethyl)-1-methyl-4H-<1,2,4>triazolo<4,3-a><1,4>benzodiazepine 
• 102671-62-5 (R)-5-(2-fluorophenyl)-3-(1H-indol-3-ylmethyl)-2-(methylthio)-3H-1,4-benzodiazepine 
• 103195-56-8 (R)-<5-(2-fluorophenyl)-3-(1H-indol-3-ylmethyl)-3H-1,4-benzodiazepine-2-yl>hydrazine 
• 108869-09-6 (R)-1,3-dihydro-5-(2-fluorophenyl)-3-(1H-indol-3-ylmethyl)-2H-1,4-benzodiazepine 

Relevant academic research and scientific papers

Triazolobenzodiazepines

Pharmaceutical compositions containing Triazolobenzodiazepines of the formula: STR1 are disclosed which are useful in the treatment of panic disorder or anxiety disorder.

Benzodiazepine analogs

Benzodiazepine analogs of the formula: STR1 are disclosed which are antagonists of gastrin and cholecystokinin (CCK).

Benzodiazepine analogs and use as antogonists of gastrin and cholecystokinin

Benzodiazepines of the formula: STR1 are disclosed which are antagonists of gastrin and cholecystokinin (CCK).

Cholestokinin Antagonists. Synthesis and Biological Evaluation of 4-Substituted 4H-Triazolobenzodiazepines

A series of 4-substituted 4H-triazolobenzodiazepines was prepared by standard metodology.These compounds were tested in vitro as antagonists of the binding of cholestokinin (CCK) to rat pancreas and guinea pig brain receptors and

Triazolobenzodiazepines and pharmaceutical use

Triazolobenzodiazepines of the formula: STR1 are disclosed which are antagonists of cholecystokinin (CCK).

Design of Nonpeptidal Ligands for a Peptide Receptor: Cholecystokinin Antagonists

A series of 3-substituted-5-phenyl-1,4-benzodiazepines, nonpeptidal antagonists of the peptide hormone cholecystokinin (CCK), have been synthesized.Designed on the basis of facts regarding CCK, its natural-product antagonist asperlicin (3), and the antian